MCID: BRS001
MIFTS: 32

Breast Lymphoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Breast Lymphoma

MalaCards integrated aliases for Breast Lymphoma:

Name: Breast Lymphoma 12 14 69
Malignant Lymphoma of Breast 12
Lymphoma of the Breast 12
Lymphoma of Breast 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5826
SNOMED-CT 64 278052009
UMLS 69 C0349669

Summaries for Breast Lymphoma

MalaCards based summary : Breast Lymphoma, also known as malignant lymphoma of breast, is related to lymphoma and raynaud disease. An important gene associated with Breast Lymphoma is PIBF1 (Progesterone Immunomodulatory Binding Factor 1), and among its related pathways/superpathways is B Cell Development Pathways. The drugs Dermatologic Agents and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include breast, b cells and bone.

Related Diseases for Breast Lymphoma

Diseases related to Breast Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 40)
id Related Disease Score Top Affiliating Genes
1 lymphoma 10.5
2 raynaud disease 10.2 CD5 SMUG1
3 polyembryoma of the ovary 10.1 BCL6 SMUG1
4 blake pouch cyst 10.0 BCL6 CD5
5 pediatric lymphoma 10.0 BCL6 CD5
6 childhood spinal cord tumor 10.0 BCL6 CD5
7 mixed type thymoma 10.0 CD5 SMUG1
8 melanoma metastasis 9.9 BCL6 CD5
9 syngnathia cleft palate 9.9 BCL6 CD5
10 arcus senilis 9.8 ALK SMUG1
11 large cell neuroendocrine carcinoma 9.8 ALK SMUG1
12 endometrioid ovary carcinoma 9.8 ALK SMUG1
13 lymphoma, malt, somatic 9.8 BCL6 CD5
14 malignant teratoma 9.7 C21orf59 CD5 SMUG1
15 breast cancer 9.7
16 polycystic ovary syndrome 9.7 ALK BCL6
17 megakaryocytic leukemia 9.6 BCL6 CD5
18 villoglandular endometrial endometrioid adenocarcinoma 9.6 BCL6 CD5 SMUG1
19 rheumatoid arthritis 9.6
20 arthritis 9.6
21 b-cell lymphomas 9.6
22 mastitis 9.6
23 gynecomastia 9.6
24 brown-vialetto-van laere syndrome 9.6 ALK SMUG1
25 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.6 ALK BCL6
26 hodgkin lymphoma 9.4
27 breast reconstruction 9.4
28 diffuse large b-cell lymphoma 9.4
29 intraocular lymphoma 9.4
30 cervicitis 9.4
31 rosai-dorfman disease 9.4
32 b-cell lymphoma of mucosa-associated lymphoid tissue 9.4
33 carnitine-acylcarnitine translocase deficiency 9.4 ALK BCL6
34 bipolar disorder 9.4 BCL6 CD5
35 uterine ligament endometrioid adenocarcinoma 9.4 ALK CD5 SMUG1
36 penile disease 9.2 ALK BCL6 CD5
37 estrogen-receptor positive breast cancer 9.2 ALK BCL6 CD5
38 drug-induced hepatitis 9.2 ALK BCL6 CD5
39 smoking as a quantitative trait locus 1 9.2 ALK BCL6 CD5
40 cervical endometrioid adenocarcinoma 7.9 ALK BCL6 C21orf59 CD5 PIBF1 SMUG1

Graphical network of the top 20 diseases related to Breast Lymphoma:



Diseases related to Breast Lymphoma

Symptoms & Phenotypes for Breast Lymphoma

Drugs & Therapeutics for Breast Lymphoma

Drugs for Breast Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 345)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Dermatologic Agents Phase 4,Phase 3,Phase 1,Phase 2
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 1,Phase 2 50-18-0, 6055-19-2 2907
3
Doxorubicin Approved, Investigational Phase 3,Phase 1,Phase 2 23214-92-8 31703
4
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
5
Melphalan Approved Phase 3,Phase 1,Phase 2 148-82-3 4053 460612
6
Everolimus Approved Phase 3,Phase 1,Phase 2 159351-69-6 6442177
7
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
8
Sirolimus Approved, Investigational Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
9
Levofloxacin Approved, Investigational Phase 3 100986-85-4 149096
10
Ofloxacin Approved Phase 3 82419-36-1 4583
11
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
12
rituximab Approved Phase 3,Phase 2,Phase 1 174722-31-7 10201696
13
Denosumab Approved Phase 3,Phase 2 615258-40-7
14
Zoledronic acid Approved Phase 3 118072-93-8 68740
15
Carmustine Approved Phase 3,Phase 2 154-93-8 2578
16
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
17
Mechlorethamine Approved Phase 3,Phase 1 51-75-2 4033
18
Exemestane Approved, Investigational Phase 3,Phase 1 107868-30-4 60198
19
Tamoxifen Approved Phase 3,Phase 2 10540-29-1 2733526
20
Capecitabine Approved, Investigational Phase 3,Phase 1 154361-50-9 60953
21
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
22
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
23
Estradiol Approved, Investigational, Vet_approved Phase 3,Phase 1 50-28-2 5757
24
Fulvestrant Approved, Investigational Phase 3,Phase 1 129453-61-8 104741 17756771
25
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2 83-43-2 6741
26
Prednisolone Approved, Vet_approved Phase 3,Phase 2 50-24-8 5755
27
Fludarabine Approved Phase 3,Phase 1,Phase 2 21679-14-1, 75607-67-9 30751
28
Cytarabine Approved, Investigational Phase 3,Phase 2,Phase 1 147-94-4 6253
29
Anastrozole Approved, Investigational Phase 3 120511-73-1 2187
30
Goserelin Approved Phase 3 65807-02-5 47725 5311128
31
Letrozole Approved, Investigational Phase 3,Phase 2,Phase 1 112809-51-5 3902
32
Leuprolide Approved, Investigational Phase 3 53714-56-0 3911 657181
33
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
34
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
35
Crizotinib Approved Phase 3,Phase 2 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
36
Obinutuzumab Approved Phase 3,Phase 2 949142-50-1
37
Vidarabine Approved Phase 3,Phase 2,Phase 1 24356-66-9 32326 21704
38
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
39
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
40
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
41
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
42
Norgestimate Approved Phase 3 35189-28-7 6540478
43
Cholecalciferol Approved, Nutraceutical Phase 3 67-97-0 6221 10883523 5280795
44
Ergocalciferol Approved, Nutraceutical Phase 3,Phase 1 50-14-6 5280793
45
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3,Phase 1 1406-16-2
46
Doxil Approved June 1999 Phase 3,Phase 1,Phase 2 31703
47 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
48 Anti-Infective Agents Phase 3,Phase 1,Phase 2
49 Topoisomerase Inhibitors Phase 3,Phase 1,Phase 2
50 Alkylating Agents Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 221)

id Name Status NCT ID Phase Drugs
1 A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer Completed NCT00277160 Phase 4 Neulasta (pegfilgrastim)
2 The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy Recruiting NCT02905916 Phase 4 PEG-rhG-CSF
3 Assessment and Tracking of Long-term Alefacept Safety Terminated NCT00454701 Phase 4 Alefacept exposure
4 Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis Completed NCT00243685 Phase 2, Phase 3
5 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
6 Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women Completed NCT01052051 Phase 3
7 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Completed NCT00004179 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
8 Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma. Completed NCT00330759 Phase 3 Zoledronic Acid
9 Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma. Recruiting NCT02964858 Phase 3
10 Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy Recruiting NCT01901094 Phase 3
11 Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Recruiting NCT02443077 Phase 3 Carmustine;Cyclophosphamide;Cytarabine;Etoposide;Ibrutinib;Melphalan
12 Breast Cancer WEight Loss Study (BWEL Study) Recruiting NCT02750826 Phase 3
13 S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Recruiting NCT01674140 Phase 3 anastrozole;everolimus;exemestane;goserelin acetate;letrozole;leuprolide acetate;tamoxifen citrate
14 Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy Recruiting NCT02445391 Phase 3 Capecitabine;Carboplatin;Cisplatin
15 Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Recruiting NCT02927249 Phase 3 Aspirin
16 Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Recruiting NCT01272037 Phase 3 Anastrozole;Exemestane;Letrozole;Systemic Chemotherapy;Tamoxifen Citrate
17 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Recruiting NCT01953588 Phase 3 fulvestrant;anastrozole
18 Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Recruiting NCT02201992 Phase 3 Crizotinib
19 A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) Active, not recruiting NCT01332968 Phase 3 Obinutuzumab;Cyclophosphamide;Doxorubicin;Vincristine;Prednisone;Bendamustine;Rituximab
20 Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Active, not recruiting NCT02048813 Phase 3 Cyclophosphamide;Fludarabine Phosphate;Ibrutinib
21 Methylphenidate Study in Breast or Gastrointestinal Cancer Patients Terminated NCT00516269 Phase 3 Methylphenidate;Placebo
22 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
23 A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma Unknown status NCT01065805 Phase 1, Phase 2
24 Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis Unknown status NCT00574587 Phase 1, Phase 2 Vorinostat;Paclitaxel;Trastuzumab;Doxorubicin;Cyclophosphamide;Post surgery therapy (Trastuzumab)
25 Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans Unknown status NCT02340845 Phase 2
26 Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor Unknown status NCT01175096 Phase 1, Phase 2 RAD001 (everolimus, Afinitor®)
27 Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia Unknown status NCT00271063 Phase 1, Phase 2 Liposomal Annamycin
28 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
29 Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer Completed NCT00256360 Phase 2 dose dense with neulasta
30 Phase II ABT-888 With Cyclophosphamide Completed NCT01306032 Phase 2 ABT-888;Cyclophosphamide
31 Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma Completed NCT00705250 Phase 2 bendamustine hcl
32 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
33 Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer Completed NCT00237627 Phase 1, Phase 2 PS-341;Doxil;Velcade
34 Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release Completed NCT01205503 Phase 2 Mesna;Saline;Doxorubicin;Cyclophosphamide
35 Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer Completed NCT00365287 Phase 1, Phase 2 anti-thymocyte globulin;cyclophosphamide;cyclosporine;fludarabine phosphate;mycophenolate mofetil
36 Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors Completed NCT00003269 Phase 2 amifostine trihydrate;cisplatin;cyclophosphamide;etoposide
37 Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma Completed NCT01177397 Phase 1, Phase 2 CC-223
38 Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect Completed NCT00003425 Phase 1, Phase 2 amifostine trihydrate;cyclophosphamide;melphalan
39 High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma Completed NCT00586014 Phase 2
40 PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Completed NCT00303953 Phase 2 belinostat
41 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors Completed NCT00060255 Phase 2 busulfan;carboplatin;carmustine;cyclophosphamide;etoposide;melphalan;thiotepa
42 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
43 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
44 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Completed NCT00064311 Phase 1, Phase 2 ravuconazole
45 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
46 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
47 PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) Completed NCT00043368 Phase 2 PF-3512676
48 Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting Completed NCT01387841 Phase 2
49 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
50 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2

Search NIH Clinical Center for Breast Lymphoma

Genetic Tests for Breast Lymphoma

Anatomical Context for Breast Lymphoma

MalaCards organs/tissues related to Breast Lymphoma:

39
Breast, B Cells, Bone, Bone Marrow, Skin, Testes, Lymph Node

Publications for Breast Lymphoma

Articles related to Breast Lymphoma:

(show top 50) (show all 142)
id Title Authors Year
1
Primary Breast Lymphoma in the United States: 1975-2013. ( 28376147 )
2017
2
Role of core needle biopsy in primary breast lymphoma. ( 28510806 )
2017
3
Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy? ( 28375194 )
2017
4
Primary breast lymphoma: a case report. ( 28270358 )
2017
5
Primary breast lymphoma: A single center study. ( 28356993 )
2017
6
Breast lymphoma in a patient with B-cell Non Hodgkin Lymphoma: A case report study. ( 28915427 )
2017
7
Primary Breast Lymphoma-Population-Level Insights into an Infrequent but Increasingly Recognized Subtype of Lymphoma. ( 28376146 )
2017
8
Primary Breast Lymphoma: A Case Report and Review of the Literature. ( 28839526 )
2017
9
Diffuse Large B-Cell Breast Lymphoma: A Case Series. ( 28839450 )
2017
10
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group. ( 27847267 )
2016
11
Primary Breast Lymphoma in a Woman: A Case Report and Review of the Literature. ( 26893404 )
2016
12
Sonoelastography of Breast Lymphoma. ( 26808169 )
2016
13
Breast Lymphoma Treatment Outcomes in a Pakistani Population: 20 Years of Experience at a Single Center. ( 27510022 )
2016
14
Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature. ( 27225235 )
2016
15
Primary breast lymphoma with progression to the scalp. ( 26458702 )
2015
16
Report of a case of primary breast lymphoma highlighting the importance of fine needle aspiration cytology as an initial diagnostic tool. ( 26229252 )
2015
17
First pathological study of canine primary breast lymphoma and the description of its clinicopathological characteristics as an animal model for human primary breast lymphoma. ( 25469251 )
2015
18
Primary breast lymphoma presenting as non-healing axillary abscess. ( 26446318 )
2015
19
MRI features of breast lymphoma: preliminary experience in seven cases. ( 26380896 )
2015
20
Clinicopathological features of thirty patients with primary breast lymphoma and review of the literature. ( 25572809 )
2015
21
F-18 FDG PET/MRI findings of primary breast lymphoma in two cases: FDG PET/MRI findings of primary breast lymphoma. ( 25748090 )
2015
22
Synchronous breast cancer and breast lymphoma: two case reports and literature review. ( 25035665 )
2014
23
Isolated cerebellar hypermetabolism on FDG PET in a case of remitted primary breast lymphoma. ( 24591788 )
2014
24
Primary breast lymphoma. ( 24953564 )
2014
25
Breast lymphoma combined with postoperative acute hematopoietic disorder in an immediate breast reconstruction patient. ( 24491455 )
2014
26
Primary breast lymphoma: 30 years of experience with diagnosis and treatment at a single medical center. ( 24257833 )
2014
27
Primary breast lymphoma: A single-institute experience in Taiwan. ( 25179707 )
2014
28
Primary diffuse large B-cell lymphoma of the nipple: a rare case of breast lymphoma localized in the nipple. ( 23316783 )
2013
29
Three Cases of Combined Therapy in Primary Breast Lymphoma (PBL) with Successful Outcomes. ( 23885182 )
2013
30
Primary breast lymphoma. ( 23906238 )
2013
31
Breast lymphoma presenting as gynecomastia in male patient. ( 23815269 )
2013
32
Primary breast lymphoma in males-a report of two cases with a review of the literature. ( 24723970 )
2013
33
The features of breast lymphoma on MRI. ( 24029630 )
2013
34
Cytodiagnosis of the primary breast lymphoma in a young woman. ( 24648678 )
2013
35
MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review. ( 23846235 )
2013
36
Unusual breast neoplasm: primary breast lymphoma. ( 23749857 )
2013
37
Primary breast lymphoma: a single institution's experience. ( 23646311 )
2013
38
Bilateral primary breast lymphoma in a teenage girl with multi-organ involvement. ( 24026996 )
2013
39
Treatment and outcomes of primary breast lymphoma. ( 23018097 )
2012
40
Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. ( 22665932 )
2012
41
Synchronous bilateral primary breast lymphoma. ( 22616682 )
2012
42
Primary breast lymphoma sequentially relapsed in the peripheral and central nervous system. ( 22426680 )
2012
43
Fusion PET-CT detection of neurolymphomatosis originating from primary breast lymphoma: A case report and literature review. ( 23162634 )
2012
44
Primary breast lymphoma: a rare entity. ( 22470790 )
2011
45
Primary breast lymphoma clinically mimicking acute mastitis: a case report. ( 21617722 )
2011
46
Primary breast lymphoma with sudden death. ( 21512383 )
2011
47
Breast lymphoma complicating anti-tumor necrosis factor therapy in rheumatoid arthritis. ( 21729669 )
2011
48
A rare case of male primary breast lymphoma. ( 22323922 )
2011
49
Primary breast lymphoma - a review of the literature and report of three cases. ( 22291729 )
2011
50
Analysis of 31 cases of primary breast lymphoma: the effect of nodal involvement and microvascular density. ( 21454188 )
2011

Variations for Breast Lymphoma

Expression for Breast Lymphoma

Search GEO for disease gene expression data for Breast Lymphoma.

Pathways for Breast Lymphoma

Pathways related to Breast Lymphoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.35 BCL6 CD5

GO Terms for Breast Lymphoma

Sources for Breast Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....